Profile data is unavailable for this security.
About the company
Tianda Pharmaceuticals Ltd is an investment holding company mainly engaged in the pharmaceutical business. The Company operates its business through three segments. The Pharmaceuticals and Medical Technologies Business segment is mainly engaged in the sale of pharmaceutical, biotechnology and healthcare products. The segment is also engaged in the provision of contract development and manufacturing organisation (CDMO) services. The Chinese Medicine Business segment is mainly engaged in the sale of Chinese medicine products. The Medical and Healthcare Services segment is mainly engaged in the sale of healthcare and Chinese medicine products. The segment is also engaged in the provision of Chinese medical services. Additionally, the Company is engaged in the sales of Chinese herbal medicines, traditional Chinese medicine decoction pieces and Chinese medicine.
- Revenue in HKD (TTM)310.50m
- Net income in HKD-67.37m
- Incorporated--
- Employees624.00
- LocationTianda Pharmaceuticals LtdSuites2405-2410, 24th Floor, CITIC TowerNo.1 Tim Mei AvenueCentral Hong KongHKG
- Phone+852 25453313
- Fax+852 25416558
- Websitehttps://www.tiandapharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sanai Health Industry Group Co Ltd | 108.27m | -37.61m | 64.98m | 147.00 | -- | 0.1877 | -- | 0.6002 | -0.2459 | -0.1179 | 0.7078 | 2.26 | 0.1994 | 8.97 | 9.71 | 660,201.80 | -7.70 | 3.50 | -10.97 | 5.00 | 17.61 | 37.40 | -38.60 | 10.86 | 2.58 | -6.86 | 0.1487 | 0.00 | -20.92 | 0.8085 | -176.60 | -- | -9.02 | -- |
| Kontafarma China Holdings Ltd | 891.73m | -362.77m | 173.25m | 655.00 | -- | 0.2529 | -- | 0.1943 | -0.065 | -0.065 | 0.1598 | 0.1226 | 0.6269 | 4.43 | 7.06 | 1,296,115.00 | -29.24 | -2.95 | -39.76 | -4.38 | 55.36 | 55.42 | -46.64 | -7.85 | 0.8036 | -- | 0.2753 | -- | 10.93 | -0.5183 | -161.89 | -- | -31.47 | -- |
| PuraPharm Corp Ltd | 346.76m | -38.56m | 176.85m | 469.00 | -- | 1.29 | 12.13 | 0.51 | -0.0976 | -0.0976 | 0.8778 | 0.2568 | 0.4749 | 1.39 | 6.98 | 723,920.70 | -5.28 | -6.50 | -15.35 | -14.97 | 53.93 | 59.22 | -11.12 | -14.08 | 0.3313 | -1.14 | 0.7865 | -- | -6.09 | -11.30 | 66.59 | -- | -29.92 | -- |
| Extrawell Pharmaceutical Holdings Ltd | 52.65m | -337.89m | 201.45m | 161.00 | -- | 0.2257 | -- | 3.83 | -0.1351 | -0.1352 | 0.0219 | 0.3501 | 0.0422 | 10.54 | 5.89 | 322,975.50 | -27.00 | 3.07 | -28.13 | 3.21 | 42.41 | 47.65 | -640.53 | 59.77 | 13.00 | -0.037 | 0.146 | -- | -6.21 | -6.50 | 236.70 | 21.75 | 80.07 | -- |
| Tianda Pharmaceuticals Ltd | 310.50m | -67.37m | 221.45m | 624.00 | -- | 0.4557 | -- | 0.7132 | -0.0313 | -0.0313 | 0.1444 | 0.226 | 0.3931 | 2.84 | 5.14 | 442,937.20 | -8.57 | -- | -12.38 | -- | 42.76 | -- | -21.80 | -- | 0.6900 | -15.81 | 0.2183 | -- | -37.99 | -- | -154.07 | -- | -- | -- |
| Shenzhen Neptunus Intrlng Bi tchnq CoLtd | 1.12bn | 6.98m | 266.80m | 1.47k | 38.19 | 0.3335 | 6.36 | 0.2375 | 0.0042 | 0.0042 | 0.6695 | 0.4768 | 0.783 | 3.68 | 5.65 | 756,546.90 | -0.4295 | 2.52 | -0.6329 | 3.76 | 29.12 | 43.41 | -0.5486 | 3.33 | 1.48 | 2.03 | 0.1157 | 139.17 | -2.18 | -0.7356 | 3.68 | -15.97 | -7.87 | -- |
| Regent Pacific Group Ltd | 7.15m | -31.86m | 294.73m | 17.00 | -- | -- | -- | 41.20 | -0.1388 | -0.1388 | 0.0312 | -0.1117 | 1.20 | -- | 6.96 | 420,776.20 | -535.26 | -47.86 | -- | -61.88 | -- | -- | -445.46 | -1,658.64 | -- | -11.90 | -- | -- | 153.63 | 2.17 | 82.11 | -- | -5.59 | -- |
| Hin Sang Group (Interntnl) Hldng Co Ltd | 95.53m | -40.10m | 316.62m | 185.00 | -- | 2.23 | -- | 3.31 | -0.0367 | -0.0367 | 0.0875 | 0.1299 | 0.1679 | 2.42 | 12.62 | 459,278.80 | -7.03 | -5.77 | -13.64 | -8.41 | 67.28 | 58.19 | -41.89 | -36.55 | 0.0735 | -0.3333 | 0.7032 | -- | -0.7882 | -12.21 | -34.48 | -- | -50.36 | -- |
| Wai Yuen Tong Medicine Holdings Ltd | 721.27m | -13.83m | 416.29m | 726.00 | -- | 0.3519 | 5.63 | 0.5772 | -0.0123 | -0.0123 | 0.6411 | 1.05 | 0.4165 | 1.41 | 9.68 | 950,292.50 | -0.7998 | -1.81 | -1.06 | -3.10 | 49.87 | 44.67 | -1.92 | -11.19 | 0.7806 | -- | 0.2033 | -- | -4.92 | 3.73 | 126.62 | -56.16 | 31.89 | -- |
| China NT Pharma Group Co Ltd | 21.11m | -80.23m | 519.17m | 21.00 | -- | -- | -- | 24.60 | -0.2327 | -0.2327 | 0.0487 | -0.4646 | 0.0546 | -- | 3.09 | 959,413.10 | -20.76 | -10.31 | -- | -- | 51.27 | -- | -380.13 | -97.11 | 0.0447 | -0.3973 | 7.95 | -- | 415.34 | -24.38 | -59.32 | -- | -71.03 | -- |
| Fusen Pharmaceutical Co Ltd | 272.63m | -197.95m | 554.48m | 1.05k | -- | 1.41 | -- | 2.03 | -0.2678 | -0.2678 | 0.3688 | 0.5303 | 0.1875 | 1.11 | 4.05 | 241,048.90 | -13.62 | -2.83 | -32.04 | -5.40 | 41.39 | 51.61 | -72.61 | -8.00 | 0.4241 | -0.4344 | 0.5137 | -- | -42.36 | -4.36 | -420.39 | -- | -17.55 | -- |
| Zhongzhi Pharmaceutical Holdings Ltd | 2.27bn | 23.25m | 647.70m | 2.49k | 27.22 | 0.5273 | 4.50 | 0.2853 | 0.0276 | 0.0276 | 2.69 | 1.42 | 1.05 | 2.66 | 6.45 | 880,969.60 | 1.09 | 6.77 | 1.68 | 10.47 | 57.19 | 59.64 | 1.03 | 5.91 | 1.06 | 51.80 | 0.1134 | 38.97 | 8.05 | 10.54 | -41.51 | -3.65 | 13.62 | 10.79 |
Data as of Feb 12 2026. Currency figures normalised to Tianda Pharmaceuticals Ltd's reporting currency: Hong Kong Dollar HKD
